Obesity in the UK 2026: 50+ Statistics on Prevalence, Demographics, Health Costs, and Where the UK Ranks Globally

Published on: April 28, 2026

Medically reviewed by

Ashis Tandukar

Superintendent Pharmacist · Reg: GPhC No. 2084170

30% of adults in England were living with obesity in 2024, the highest figure ever recorded by the Health Survey for England, the country's flagship study tracking population health since 1993. Two thirds (66%) of adults were either overweight or obese. Among children leaving primary school, 22.2% were obese, rising to 29.3% in the most deprived areas — more than double the 13.5% in the least deprived.

These numbers are the underlying reason the UK has become the largest anti-obesity medication market in Europe, why the NHS now records over 1.2 million obesity-related hospital admissions a year, and why Frontier Economics and Nesta now estimate the total annual cost to the UK economy at £126 billion.

We pulled the most recent UK obesity figures from the Health Survey for England 2024, the Office for Health Improvement and Disparities (OHID), the National Child Measurement Programme, the Scottish Health Survey 2024, the National Survey for Wales, the Health Survey Northern Ireland, NHS Digital hospital admissions data, the Frontier Economics/Nesta cost analysis, Cancer Research UK projections and OECD Health at a Glance 2025 — every figure traced back to its primary source and dropped if we couldn't verify it.

What follows is a 2026 snapshot of how big the UK obesity problem actually is, who it affects, what it costs, and where it is heading.

1. Adult obesity in England: how big the problem actually is

The single most authoritative number for UK obesity comes from the Health Survey for England, because it uses measured height and weight rather than self-report. Its 2024 results, published in January 2026, found that 30% of adults aged 16 and over were living with obesity (BMI ≥ 30) and 66% were either overweight or obese. Prevalence rose rapidly between 1993 and 2008 — from 15% to 25% — and has continued upward since, reaching the highest level on record in the latest data. OHID's separate Obesity Profile, which adjusts self-reported figures from the Active Lives Adult Survey, put 2023/24 obesity prevalence slightly lower at 26.5%, with 64.5% overweight or obese. Both confirm the same direction of travel: roughly two thirds of English adults are now above a healthy weight.

The gap between the HSE figure (30%) and the OHID figure (26.5%) reflects methodology, not real-world disagreement. HSE uses trained interviewers measuring participants directly, which is more accurate but expensive and slow to publish. OHID's Active Lives data is self-reported (people consistently under-report weight and over-report height) and then adjusted using a prediction equation — useful for tracking local-authority differences, less precise for national totals. For a definitive national figure, HSE wins.

2. Childhood obesity and the deprivation gap

The National Child Measurement Programme is one of the most rigorous childhood weight datasets in the world, measuring more than 1.1 million children every academic year — a 94.1% participation rate. The 2024/25 report, published in November 2025 by the Department of Health and Social Care, painted a worrying picture. Reception obesity (age 4–5) ticked up to 10.5%, one of the highest figures since records began in 2006/07, excluding the pandemic peak. Year 6 obesity (age 10–11) remained at 22.2%, well above pre-pandemic levels. The headline statistic is that the proportion of obese children roughly doubles between Reception and Year 6 — and the deprivation gap doubles with it.

The deprivation effect is doing most of the work in the headline numbers. A Year 6 child in the most deprived decile is more than twice as likely to be obese as a peer in the least deprived decile. Public health analysts at Sheffield Hallam University noted on the 2024/25 release that the gap has widened compared with the early years of the programme — the Reception obesity rate was one of the highest recorded since measurements began, suggesting recent reductions among the youngest cohort were short-lived.

3. The four-nation picture: how England, Scotland, Wales and Northern Ireland compare

The UK does not have a single obesity statistic — each devolved nation runs its own survey, with its own methodology and its own publication cycle. Combined, the picture across the four nations is similar in scale but not identical: Scotland reports the highest measured rate, Wales the lowest official rate (likely understated by self-report), with England and Northern Ireland in the middle. Adjusted analyses by Nesta have argued Wales' true obesity rate is closer to 34% once self-reporting bias is corrected — which would make it the highest of the four nations rather than the lowest.

The common thread is that overweight prevalence has plateaued across all four nations, but obesity — particularly severe obesity — has continued to climb. The Scottish Health Survey 2024 recorded the highest mean adult BMI in its time series and the highest female obesity rate (35%) since records began. In Wales, the proportion of adults living with obesity has risen 44% in 20 years.

4. Demographics: who is most affected

Obesity in the UK is not evenly distributed. It varies sharply by age, sex, ethnicity, deprivation and region. The HSE 2024 confirmed that obesity prevalence climbs with age up to about 64, peaks at 32–33% in the 55–64 age group, then declines. OHID's 2023/24 data shows obesity prevalence is highest among adults identifying as Black (33.1%) and lowest among Asian adults — though NICE recommends lower BMI thresholds for some Asian and Black ethnic groups because cardiometabolic risk rises at lower BMIs in those populations. The deprivation gradient is the steepest single demographic effect: adults in the most deprived areas of England are roughly 70% more likely to be obese than those in the least deprived areas.

The regional pattern follows the same axis. Health Survey for England data shows the North East has consistently the highest adult obesity rate (around 34%) and London the lowest (around 22–23%). Year 6 child obesity is highest in the North East (24.5%), West Midlands (24.4%) and London (24.0%), and lowest in the South East (19.2%) and South West (19.1%) — a pattern that has barely shifted in a decade. Some of the same drivers — food environment, physical inactivity, and resistance to weight loss in metabolically stressed adults — are why many people struggle to lose weight even in a calorie deficit.

5. Obesity and disease: hospital admissions, comorbidities and mortality

Obesity is a risk factor for cardiovascular disease, type 2 diabetes, at least 13 different cancers, liver disease, respiratory disease, osteoarthritis and depression. The clinical impact shows up most clearly in hospital admissions. NHS Digital's most recent published figures recorded 1.2 million hospital admissions in 2022/23 where obesity was a primary or secondary diagnosis — an 8% rise on the previous year, and roughly double the 617,000 recorded in 2016/17. That works out at over 3,000 obesity-related admissions every day in England alone.

The most striking comorbidity link in the HSE 2024 data was waist-to-height ratio: 7 in 10 adults had a ratio above 0.5, the threshold above which cardiovascular and metabolic risk rises sharply — even in some adults who fall outside the standard obesity BMI category. Waist-based measures capture risk that BMI alone misses, particularly in adults of South Asian, Chinese, Black or Mixed ethnicity, where NICE recommends lower BMI thresholds (23 for overweight, 27.5 for obesity) precisely because cardiometabolic disease appears at lower body fat levels.

6. The economic cost: NHS, productivity and the total bill

The most rigorous current estimate of the UK economic cost of obesity comes from a July 2025 Nesta report, conducted by Frontier Economics, which put the total annual cost at £126 billion. The breakdown is the part most journalists end up citing: £71.4bn is the value of years of good-quality life lost to weight-related conditions; £30.8bn is lost productivity (absenteeism, presenteeism, economic inactivity, and earlier mortality combined); £12.6bn is direct NHS treatment cost; and £11.7bn is formal and informal social care. The 2025 productivity figure is more than double the £15bn estimated in Frontier's earlier 2023 report — the new model captures presenteeism (people being less productive while at work) and lost working years from early mortality, which the older study did not.

The productivity bill is the policy-relevant number — it is roughly equivalent to a 3p cut in the basic rate of income tax, and more than the entire additional NHS funding settlement from the most recent Spending Review. The £12.6bn NHS cost figure also explains the rapid policy shift toward GLP-1 medications: NICE's TA1026 guidance on Mounjaro for obesity projects a year-three cost of £317m, a fraction of the £12.6bn baseline disease burden, which is what makes the long-term economics work even at headline drug list prices.

7. Where it's heading: 2040 projections and the international picture

The most-cited UK obesity projection is Cancer Research UK's 2022 analysis, which used Health Survey for England data going back to 1993 to model the population trajectory under current trends. By 2040, the analysis estimates 36% of UK adults — around 21 million people — will be obese, and 71% will be overweight or obese. The deprivation gap is projected to widen further: 46% of adults in the most deprived areas will be obese, compared with 25% in the least deprived. Severe obesity (BMI ≥ 40) is projected to almost double, from around 3% to 6%. The cross-over point at which obese adults outnumber healthy-weight adults is expected to arrive in England by the late 2020s — roughly now.

The international comparison is unflattering. The OECD's 2025 Health at a Glance puts the UK among the highest obesity rates in Europe — broadly comparable with Hungary, Czechia and Croatia, and well above France (around 10%), Italy and most of Scandinavia. Only the US sits clearly above the UK among major Western economies. That ranking, combined with the £126bn cost burden and the 36% by-2040 projection, is what is now driving the rapid expansion of NHS and private weight loss medication access — the demand-side reality that the UK weight loss medication market has scaled to meet.

UK obesity by the numbers — summary

Methodology and sources

We aggregated data from primary sources only — government statistics, regulatory bodies, peer-reviewed studies and commissioned economic analyses by reputable firms — and dropped any figure we could not trace back to a Tier 1 publication. Where two sources reported figures for the same metric (NHS cost, productivity loss, Wales adult obesity prevalence), we cite both and flag the methodological difference.

Measured prevalence (Health Survey for England) is consistently higher than self-reported prevalence (OHID Active Lives, National Survey for Wales) because adults under-report weight and over-report height. For population-level totals, we lead with measured data where available and treat self-reported figures as a useful secondary check.

Primary sources used in this article:

• NHS Digital — Health Survey for England 2024 (Adults' overweight and obesity; Adults' health), published January 2026
• Department of Health and Social Care / OHID — National Child Measurement Programme annual report, academic year 2024/25, November 2025
• Office for Health Improvement and Disparities — Obesity Profile: short statistical commentary, May 2025
• Office for Health Improvement and Disparities — Obesity Profile: statistical commentary, November 2024
• Scottish Government — Scottish Health Survey 2024 — Volume 1: Main Report, October 2025
• Welsh Government — National Survey for Wales 2022-23 and 2024-25 headline results
• Public Health Wales — Child Measurement Programme 2023/24
• Northern Ireland Department of Health — Health Survey Northern Ireland 2023/24
• NHS Digital — Statistics on Public Health, England 2023 (hospital admissions and prescriptions, 2022/23)
• Nesta / Frontier Economics — The economic and productivity costs of obesity and overweight in the UK, July 2025
• Cancer Research UK — Overweight and obesity prevalence projections, 2022
• House of Commons Library — Obesity statistics research briefing (SN03336), 2025 update
• Heald A.H. et al. — Counting the lifetime cost of obesity, Diabetes, Obesity and Metabolism, 2024
• OECD — Health at a Glance 2025
• World Obesity Federation — Global Obesity Observatory, country report cards
• World Health Organization — global obesity prevalence data, 2022
• NICE — Technology Appraisal TA1026, Tirzepatide for managing overweight and obesity, December 2024

Last updated: April 2026. We revise these figures whenever the relevant primary source publishes — typically NCMP every November, HSE every January–February, OHID Obesity Profile every May, Scottish Health Survey every September–October.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any treatment.